Viewing nowNebivolol Tablet (Nebivolol Hydrochloride)
Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

MFDS item code 201104061 · Notified 2011.06.30 · Insurance code 655604260
Treatment of essential hypertension; adjunctive treatment of chronic stable heart failure in patients aged 70 years or older
This medication is commonly used as an adjunct treatment for essential hypertension and chronic heart failure, particularly in patients aged 70 and older with mild to moderate stable chronic heart failure.
1. Essential hypertension (1) Adults Administer 5mg of nebivolol orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment, although it may appear after 4 weeks in some cases. May be taken with food. (2) Patients with renal impairment The initial dose is 2.5mg of nebivolol orally once daily. If necessary, the daily dose may be increased to 5mg. (3) Older adults The initial dose for older adults aged 65 years and older is 2.5mg of nebivolol once daily. If necessary, the daily dose may be increased to 5mg. Since clinical experience in patients aged 75 years and older is insufficient, administer with careful monitoring. 2. Chronic heart failure (1) Older patients aged 70 years and older This medicine should be administered to patients with chronic stable heart failure who have had no history of acute heart failure in the past 6 weeks. Doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized by 2 weeks before starting this medicine. Considering the patient's condition, the dose should be gradually increased at intervals of 1~2 weeks until the optimal dose for each patient is reached. Start treatment with 1.25mg of nebivolol once daily and, if necessary, the dose may be increased to 2.5 mg once daily, 5 mg once daily, and up to 10 mg once daily. The maximum daily dose is 10 mg. May be taken with food. (2) Patients with renal impairment Since titration to the maximum tolerated dose is adjusted for each patient, no dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine ≥ 250 μmol/L), as there is no experience with use in these patients.
This medication should not be used in patients with certain diseases or conditions. For example, individuals allergic to this drug or those suffering from bronchial asthma, severe cardiac problems, severe hypotension, or significant liver or kidney function impairment should avoid taking it. Additionally, it is advisable for pregnant or breastfeeding women not to use this medication. Those with genetic lactose intolerance should also refrain from taking it. Patients with chronic lung diseases, heart failure, diabetes, thyroid dysfunction, and elderly patients should exercise caution when using this medication and require strict monitoring by a physician. Various side effects can occur from this medication, including common symptoms such as headache, dizziness, dyspepsia, shortness of breath, skin rash, and fatigue. Rarely, severe heart problems or neuropsychiatric symptoms may occur; if any abnormal symptoms arise, immediate consultation with a doctor is essential. This medication can interact with various other drugs, particularly calcium channel blockers, antiarrhythmics, central nervous system medications, diabetes medications, and anesthetics; caution is required when taken concurrently with these agents. Be sure to inform your doctor or pharmacist of any other medications you are currently taking. Abrupt discontinuation of this medication can exacerbate heart disease, so dosages should be gradually reduced according to a physician's instructions. In cases of overdose, severe bradycardia, hypotension, or respiratory distress may occur, necessitating immediate medical attention. Lastly, this medication is not recommended for children due to safety and efficacy not being established, whereas elderly patients should start at a low dose and use the medication while closely monitoring their condition.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air or moisture infiltration, ideally at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness.
White circular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowNebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Nebivolol Hydrochloride 5.45mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.

Nebivolol Hydrochloride 2.725mg
Tablet · Prescription medication
Erison Pharm Co., Ltd.

Nebivolol Hydrochloride 1.3625mg
Tablet · Prescription medication
Ellison Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.